![Arnaud Muller](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Provenienza dei contatti di primo grado di Arnaud Muller
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Nemis Technologies AG
![]() Nemis Technologies AG Miscellaneous Commercial ServicesCommercial Services Nemis Technologies AG provides food safety solutions through their n-light environmental monitoring series. The company is based in Dübendorf, Switzerland and was founded in 2018 by Roger Meier, Arnaud Muller, Mario Hupfeld, and Urs Breitenstein. The Swiss company's E.coli rapid test is a part of this series and enables pathogen detection in food processing. Arnaud Muller has been the CEO since 2018.
5
| Holding Company | Miscellaneous Commercial Services | 5 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Arnaud Muller tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
YPSOMED HOLDING AG | Medical Specialties | Chief Operating Officer | |
University of Karlsruhe | College/University | Graduate Degree | |
PIQUR Therapeutics AG
![]() PIQUR Therapeutics AG Pharmaceuticals: OtherHealth Technology PIQUR Therapeutics AG engages in development of anti-cancer drugs based on the inhibition. Its products include PQR309, PQR620 and PQR5xx. The company was founded by Bernd Giese, Vladimir Cmiljanovic, Andreas Emmenegger, Ralf Rosenow and Matthias Wymann in August 2011 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Other | Director/Board Member | |
Aurealis Oy
![]() Aurealis Oy BiotechnologyHealth Technology Aurealis Oy operates as a biopharmaceutical company which develops treatment method that improves life for chronic inflammation and cancer sufferers. It develops a proprietary technology, which utilizes genetically modulated probiotics that deliver a variety of therapeutic proteins to diseased tissue, thus modulating local immune system and enabling healing. The company was founded by Dirk Weber and Thomas Wirth in 2010 and is headquartered in Kuopio, Finland. | Biotechnology | Chairman | |
Clarena AG
![]() Clarena AG Miscellaneous Commercial ServicesCommercial Services Clarena AG provides business management consultancy services. The private company is based in Basel, Switzerland. The Swiss company was founded by Roger Meier. | Miscellaneous Commercial Services | Founder | |
Strekin AG
![]() Strekin AG BiotechnologyHealth Technology Strekin AG is a Swiss pharmaceutical company that develops pharmaceuticals, therapeutics, and vaccines. The private company is based in Basel, Switzerland and was founded in 2014. | Biotechnology | Director/Board Member | |
terreActive AG
![]() terreActive AG Information Technology ServicesTechnology Services Part of Die Schweizerische Post AG, terreActive AG is a company that specializes in soar, security orchestration automation and response, ki, ai. The company is based in Aarau, Switzerland. terreActive was acquired by Die Schweizerische Post AG on July 04, 2023. The Swiss company's Security Operations Center is responsible for protecting the IT security infrastructure and preventing cyber attacks. The company was founded in 1996 by Marc-Yves Bächli, Roger Meier. Urs Rufer has been the CEO of the company since 1999. | Information Technology Services | Founder | |
Qualitech AG
![]() Qualitech AG Miscellaneous Commercial ServicesCommercial Services Part of Eurofins Scientific SE, Qualitech AG is a material testing center company. Qualitech AG is based in Mägenwil, Switzerland. Qualitech was acquired by Eurofins Scientific SE on July 30, 2021. The Swiss company was founded in 1980. Roland Sigrist has been the CEO of the company since 2014. | Miscellaneous Commercial Services | Director/Board Member | |
Kinarus AG
![]() Kinarus AG Pharmaceuticals: MajorHealth Technology Part of Kinarus Therapeutics Holding AG, Kinarus AG is a Swiss clinical stage pharmaceutical company that focuses on novel treatments to patients suffering from viral, respiratory and ophthalmic diseases. The company is based in Basel, Switzerland. The company was founded in 2017 by Alexander Bausch, Roger Meier. Alexander Bausch has been the CEO since 2017. Kinarus was acquired by Perfect Holding SA on June 03, 2022. | Pharmaceuticals: Major | Founder | |
Versameb AG
![]() Versameb AG Miscellaneous Commercial ServicesCommercial Services Versameb AG operates as an preclinical-stage biopharmaceutical company. The company was founded by Friedrich Metzger, Roger Meier and Urs Breitenstein in 2018 and is headquartered in Basel, Switzerland. | Miscellaneous Commercial Services | Founder | |
Acthera Therapeutics AG
![]() Acthera Therapeutics AG BiotechnologyHealth Technology Acthera Therapeutics AG is a Swiss biotechnology company that develops synthetic lipid membrane vesicles. The private company is based in Basel, Switzerland. The CEOs are Carlo Bertozzi, Pierre-Alain Monnard. The company was founded by Roger Meier. | Biotechnology | Founder |
Statistiche
Distribuzione geografica
Svizzera | 11 |
Germania | 2 |
Finlandia | 2 |
Settori
Health Technology | 8 |
Commercial Services | 4 |
Consumer Services | 2 |
Technology Services | 2 |
Posizioni
Founder | 8 |
Director/Board Member | 6 |
Corporate Officer/Principal | 2 |
Chief Operating Officer | 2 |
Chairman | 2 |
Contatti più connessi
Insiders | |
---|---|
Roger Meier | 9 |
Frank Mengis | 5 |
Mario Hupfeld | 1 |
Urs Breitenstein | 1 |
Daniel Baer | 1 |
- Borsa valori
- Insiders
- Arnaud Muller
- Connessioni Società